Recurrent vulval fibroids--an unusual indication for selective oestrogen receptor modulators (SERMs).
Darbhamulla
A
A
Tameside General Hospital, Ashton under Lyne, UK. annadarbhamulla@yahoo.co.uk
Watson
A J S
AJ
Benatar
B
B
D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D020847:Estrogen Receptor Modulators / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D007150:Immunohistochemistry; D007889:Leiomyoma / Q000473:pathology* / Q000601:surgery; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology*; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage*; D016896:Treatment Outcome; D014846:Vulvar Neoplasms / Q000473:pathology* / Q000601:surgery
D020847:Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride